Yadi Geng
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma.
Journal: Frontiers in oncology
Published: May 03, 2026
Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspective.
Journal: Health economics review
Published: December 19, 2023
Xanthatin suppresses pancreatic cancer cell growth via the ROS/RBL1 signaling pathway: In vitro and in vivo insights.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 13, 2023
Xanthatin induce DDP-resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation.
Journal: Drug development research
Published: November 02, 2022
Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balance.
Journal: Drug development research
Published: November 24, 2021
TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling Pathways Involved in the Response to Xanthatin Treatment in Human HT-29 Colon Cancer Cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: January 14, 2021
Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration.
Journal: Drug development research
Published: January 11, 2021
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway.
Journal: Molecular therapy. Nucleic acids
Published: October 29, 2019
SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
Journal: Aging
Published: June 04, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026